Structure and Mechanism AOD-9604: A synthetic fragment of HGH (amino acids 176191) designed to selectively trigger fat metabolism without stimulating IGF-1 or growth pathways Tesamorelin: A synthetic analog of growth hormonereleasing hormone (GHRH) that stimulates the pituitary to release more endogenous HGH, which in turn elevates IGF-1 and drives both fat loss and anabolic effects Clinical Uses AOD-9604: Investigated primarily for obesity, fat metabolism, and joint/cartilage repair
PMC10706451 Brown B, Cohen L, Jackson R, et al
Somethings I appreciate the guide regarding dates, like dairy etc as can help with 'rotating' what's in your cupboards/fridge
The classic sign is the inability to touch the chin to the chest due to neck rigidity
Daily dose: 4,660mcg (4.66mg) total blend This breaks down to approximately: 3,400mcg (3.4mg) GHK-Cu 660mcg TB-500 660mcg BPC-157 Administration: Split into two daily injections, morning and evening Cycle length: 2-4 weeks maximum Schedule: Twice daily at 12-hour intervals This protocol doubles the standard dose by splitting it across two daily administrations
[4] These medications are typically prescribed in conjunction with a reduced-calorie diet and increased physical activity, as part of a comprehensive weight management program such as ours here at Rivas medical Weight Loss Potential Benefits Beyond Glycemic Control While GLP-1 agonists are primarily used for blood sugar control and weight management in type 2 diabetes, they also show promise in providing additional health benefits
